1. Home
  2. ANVS vs CKPT Comparison

ANVS vs CKPT Comparison

Compare ANVS & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • CKPT
  • Stock Information
  • Founded
  • ANVS 2008
  • CKPT 2014
  • Country
  • ANVS United States
  • CKPT United States
  • Employees
  • ANVS N/A
  • CKPT N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • CKPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANVS Health Care
  • CKPT Health Care
  • Exchange
  • ANVS Nasdaq
  • CKPT Nasdaq
  • Market Cap
  • ANVS 110.4M
  • CKPT N/A
  • IPO Year
  • ANVS 2020
  • CKPT 2017
  • Fundamental
  • Price
  • ANVS $9.57
  • CKPT $3.77
  • Analyst Decision
  • ANVS Strong Buy
  • CKPT Strong Buy
  • Analyst Count
  • ANVS 6
  • CKPT 2
  • Target Price
  • ANVS $29.67
  • CKPT $12.00
  • AVG Volume (30 Days)
  • ANVS 341.4K
  • CKPT 946.5K
  • Earning Date
  • ANVS 11-06-2024
  • CKPT 11-11-2024
  • Dividend Yield
  • ANVS N/A
  • CKPT N/A
  • EPS Growth
  • ANVS N/A
  • CKPT N/A
  • EPS
  • ANVS N/A
  • CKPT N/A
  • Revenue
  • ANVS N/A
  • CKPT $78,000.00
  • Revenue This Year
  • ANVS N/A
  • CKPT N/A
  • Revenue Next Year
  • ANVS N/A
  • CKPT $151,162.55
  • P/E Ratio
  • ANVS N/A
  • CKPT N/A
  • Revenue Growth
  • ANVS N/A
  • CKPT N/A
  • 52 Week Low
  • ANVS $4.53
  • CKPT $1.36
  • 52 Week High
  • ANVS $22.49
  • CKPT $3.95
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 58.70
  • CKPT 84.67
  • Support Level
  • ANVS $9.00
  • CKPT $2.37
  • Resistance Level
  • ANVS $10.54
  • CKPT $2.54
  • Average True Range (ATR)
  • ANVS 0.81
  • CKPT 0.27
  • MACD
  • ANVS 0.12
  • CKPT 0.10
  • Stochastic Oscillator
  • ANVS 74.57
  • CKPT 88.60

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: